Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Endothelium ; 12(3): 133-7, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16291516

RESUMEN

Viral infection induces various responses in vascular endothelial cells. Polyinosinic-polycytidylic acid (poly IC) is a synthetic double-stranded RNA (dsRNA), and treatment of cells with poly IC mimics the viral infection to the cells. Retinoic acid-inducible gene-I (RIG-I) is a protein belonging to the DExH-box family and designated as a putative RNA helicase. RIG-I is considered to play a role in antiviral responses through the regulation of gene expressions. In the present study, the authors treated human umbilical vein endothelial cells (HUVECs) with poly IC and found that poly IC induced the expression of RIG-I. The poly IC-induced RIG-I expression was inhibited by the preincubation of the cells with 2-aminopurine, an inhibitor of dsRNA-dependent protein kinase (PKR). Immunohistochemical examination revealed high levels of RIG-I immunoreactivity in vascular endothelial cells in the thalamus from rats inoculated with hantavirus. Induction of RIG-I by poly IC may be involved in the antiviral responses in endothelial cells.


Asunto(s)
Células Endoteliales/fisiología , Inductores de Interferón/farmacología , Poli I-C/farmacología , ARN Bicatenario/farmacología , Receptores de Ácido Retinoico/biosíntesis , Venas Umbilicales/fisiología , Animales , Animales Recién Nacidos , Células Cultivadas , Células Endoteliales/citología , Regulación de la Expresión Génica/efectos de los fármacos , Orthohantavirus , Infecciones por Hantavirus/metabolismo , Infecciones por Hantavirus/patología , Infecciones por Hantavirus/virología , Humanos , ARN Helicasas/biosíntesis , ARN Helicasas/genética , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Ratas , Ratas Wistar , Receptores de Ácido Retinoico/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Tálamo/metabolismo , Tálamo/patología , Tálamo/virología , Venas Umbilicales/citología , eIF-2 Quinasa/metabolismo
2.
Transplant Proc ; 37(2): 994-6, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15848601

RESUMEN

INTRODUCTION: We previously showed that proteinuria from a renal graft was significantly decreased by administration of losartan potassium, an angiotensin II receptor blockers (ARB). To further evaluate the mechanism, we performed another clinical study focusing on the change in plasma plasminogen activator inhibitor-1 (PAI-1) levels among cyclosporine (CyA)-treated renal allograft recipients. METHODS: Among 12 hypertensive CyA-treated kidney transplant patients, four received 25 to 50 mg/day of losartan; four, 4 to 8 mg/day of candesartan cilexetil; and another four, 20 to 40 mg/day of nifedipine. Four CyA-treated kidney-transplanted patients without hypertension were selected as a control group. Informed consent was obtained from all participants. PAI-1 and serum creatinine (S-Cr) levels were monitored every 3 months for 1 year. RESULTS: Considering the pretreatment of PAI-1 as 100%, the mean percent of PAI-1 at 1 year after the onset of study for losartan, candesartan, nifedipine, and control groups were 78.6 +/- 6.7%, 81.4 +/- 8.0%, 96.7 +/- 7.6%, and 110.4 +/- 9.2%, respectively. The ARB groups demonstrated significant differences from the control group (P < .01), while the nifedipine group did not. S-Cr levels among ARB-administered groups were increased slightly but temporarily. As for S-Cr levels, no significant differences were seen among the four groups. CONCLUSIONS: Control of hypertension itself is important for all renal graft recipients; however, PAI-1 reduction by ARBs was thought to be a key for renal preservation. We expect that ARBs will contribute to prolonged renal allograft survival.


Asunto(s)
Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Ciclosporina/uso terapéutico , Trasplante de Riñón/fisiología , Inhibidor 1 de Activador Plasminogénico/fisiología , Bencimidazoles/uso terapéutico , Compuestos de Bifenilo , Presión Sanguínea/efectos de los fármacos , Creatinina/sangre , Femenino , Estudios de Seguimiento , Humanos , Inmunosupresores/uso terapéutico , Trasplante de Riñón/inmunología , Losartán/uso terapéutico , Masculino , Persona de Mediana Edad , Nifedipino/uso terapéutico , Tetrazoles/uso terapéutico , Trasplante Homólogo/inmunología , Trasplante Homólogo/fisiología
4.
Plant Cell Physiol ; 36(3): 505-10, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7757340

RESUMEN

A cDNA clone for a polypeptide that contained seven repetitive segments of the Trp-Asp forty-amino-acid repeat (WD-40 repeat) was isolated from a cDNA library prepared from the greening leaves of rice. The cDNA was 1,285 bp long and contained an open reading frame that encoded a protein of 334 amino acid residues, which was designated it RWD (rice protein containing the WD-40 repeat). RWD exhibited greater homology to a group of receptor for activated C-kinase (RACK), a product of auxin-regulated gene from cultured cells (arcA) and a Chlamydomonas beta subunit-like polypeptide (Cblp) rather than to the beta subunits of heterotrimeric G protein complexes. The mRNA for RWD (1.3 kb) was found in all organs of rice plants, in particular, in roots. Therefore, RWD is suggested to be a protein that is expressed constitutively.


Asunto(s)
Oryza/genética , Proteínas de Plantas/genética , Secuencia de Aminoácidos , Secuencia de Bases , Secuencia de Consenso , ADN Complementario/genética , Proteínas de Unión al GTP/metabolismo , Datos de Secuencia Molecular , Hojas de la Planta/metabolismo , Proteína Quinasa C/metabolismo , Secuencias Repetitivas de Ácidos Nucleicos
5.
Plant Mol Biol ; 26(1): 403-14, 1994 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7948886

RESUMEN

A potato gene encoding cathepsin D inhibitor (CDI) is expressed constitutively in tubers and flower buds and it is inducible in leaves upon wounding of the tissue or by treatment with methyl jasmonate (MJA). A fusion gene (CDI:GUS) in which the 2.4 kb long promoter of the CDI gene was translationaly fused with the coding sequence for beta-glucuronidase (GUS) showed MJA-inducible expression in transformed tobacco cells in suspension. The maximum level of induction by MJA was obtained in the absence of auxin and repression of MJA-inducible expression of the fusion gene by auxin was released by aphidicolin, the results suggesting that MJA-inducible expression is repressed during active cell division. JA and MJA showed similar activities in inducing the expression of the fusion gene, while other JA-related compounds such as cucurbic acid, tuberonic acid and dihydrojasmonic acid neither induced expression of the fusion gene nor inhibited the MJA-inducible expression of the fusion gene. Methyl dihydrojasmonate specifically stimulated the MJA-inducible expression of the fusion gene. The MJA-inducible expression of the fusion gene was observed even with a 100 bp long promoter of the CDI gene albeit with significantly decreased level of expression compared to the 2.4 kb long promoter. The 100 bp long CDI promoter did not contain a G-box or hexamer motif that had been implicated in the MJA-responsive expression of several other plant genes. Further mutagenesis of the 100 bp long promoter by deletion or oligonucleotide insertion suggested that although a sequence between -100 and -82 is required for the MJA-responsive expression, the presence of this sequence alone does not confer the MJA-responsive expression.


Asunto(s)
Acetatos/farmacología , Catepsinas/antagonistas & inhibidores , Ciclopentanos/farmacología , Regulación de la Expresión Génica de las Plantas/efectos de los fármacos , Nicotiana/genética , Proteínas de Plantas/genética , Plantas Tóxicas , Regiones Promotoras Genéticas/genética , Ácido 2,4-Diclorofenoxiacético/farmacología , Adenina/análogos & derivados , Adenina/farmacología , Afidicolina/farmacología , Secuencia de Bases , Células Cultivadas , Genes Reporteros , Glucuronidasa/genética , Glucuronidasa/metabolismo , Datos de Secuencia Molecular , Oxilipinas , Proteínas Recombinantes de Fusión/biosíntesis , Eliminación de Secuencia/fisiología , Solanum tuberosum/química
6.
Plant Cell Physiol ; 35(2): 303-12, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8069493

RESUMEN

Potato tubers contain a complex group of proteins of 20 to 24 kDa that exhibit homology to Kunitz-type proteinase inhibitors. We isolated three cDNAs and two genomic clones that encode members of the potato Kunitz-type proteinase inhibitor (PKPI) family. Comparison of the structures of these and other cloned genes indicated that genes of the PKPI family can be classified into three major homology groups, namely, A, B and C. The PKPI-A and -B genes exhibit higher homology to one another than to the PKPI-C genes. Determination of the N-terminal amino acid sequences of 18 polypeptides from the complex group of 20- to 24-kDa proteins that had been separated by column chromatography and subsequently gel electrophoresis revealed three different sequences that corresponded to PKPI-A, -B, and -C. PKPI-A genes include those coding for a cathepsin D inhibitor, while PKPI-B and -C genes include those coding for trypsin and/or chymotrypsin inhibitors and a subtilisin inhibitor. Precursors to PKPIs are synthesized with an N-terminal extra peptide that appears to contain, in addition to the signal peptide, a short propeptide with a highly conserved Asn-Pro-Ile-Xxx-Leu-Pro motif that is identical to the potential vacuolar-sorting determinant in the N-terminal propeptide of a precursor to sporamin of sweet potato. Expression of the PKPI-A and -B genes is differentially regulated: PKPI-A mRNA but not PKPI-B mRNA were induced in leaves after wounding or upon treatment with methyl jasmonate. Nuclear genes for PKPI-A and -B do not contain introns, and the homology between the two types of gene extends only 72 bp upstream from the site of initiation of transcription.


Asunto(s)
Genes de Plantas , Familia de Multigenes , Solanum tuberosum/genética , Inhibidor de la Tripsina de Soja de Kunitz/genética , Secuencia de Aminoácidos , Secuencia de Bases , Southern Blotting , ADN , Regulación de la Expresión Génica , Datos de Secuencia Molecular , Proteínas de Plantas/genética , Homología de Secuencia de Aminoácido , Homología de Secuencia de Ácido Nucleico , Inhibidor de la Tripsina de Soja de Kunitz/biosíntesis , Inhibidor de la Tripsina de Soja de Kunitz/química
7.
Cancer Chemother Pharmacol ; 33 Suppl: S42-7, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-8137484

RESUMEN

For the purpose of achieving emergency hemostasis of a ruptured hepatocellular carcinoma (HCC) or prevention of such rupture, we applied a new method of transcatheter therapy: intra-arterial alcoholization. Five patients with a ruptured HCC and 42 with an impending rupture were treated by intra-arterial injection of absolute ethanol mixed with an equal volume of iodized oil, Lipiodol (EtOH-Lp). The tumor size ranged from 4 to 26 cm (mean 7.8 cm) in diameter. The catheter tip was placed in the segmental branch or a more distal position of the hepatic artery, and 2-40 (mean 10.6) ml of EtOH-Lp was infused under fluoroscopic guidance. Infiltration of ethanol into the HCC mass was recognized as a dense deposition of Lipiodol on plain abdominal X-rays and computed-tomography. In all five cases of ruptured HCC, hemostasis was achieved. In all 42 cases of impending rupture, tumor rupture was prevented, and all except 3 patients could be discharged. No significant complication of the gastrointestinal tract or biliary tract was seen. The incidence and severity of postembolization syndrome was markedly lower than those seen in cases treated with Gelfoam embolization.


Asunto(s)
Carcinoma Hepatocelular/terapia , Embolización Terapéutica , Etanol/administración & dosificación , Aceite Yodado/administración & dosificación , Neoplasias Hepáticas/terapia , Hígado/patología , Adolescente , Adulto , Anciano , Carcinoma Hepatocelular/complicaciones , Femenino , Humanos , Inyecciones Intraarteriales , Cirrosis Hepática/complicaciones , Neoplasias Hepáticas/complicaciones , Masculino , Persona de Mediana Edad , Rotura Espontánea/prevención & control
8.
Hinyokika Kiyo ; 38(10): 1165-9, 1992 Oct.
Artículo en Japonés | MEDLINE | ID: mdl-1481777

RESUMEN

A 58-year-old male patient was admitted to the hospital complaining of weight loss. Abdominal computerized tomographic (CT) scan disclosed a mass shadow in the left kidney. From the results of further examination, including drip infusion pyelography (DIP) and angiography, he was preoperatively diagnosed as having a left renal tumor. Left radical nephrectomy was performed on March 15, 1990. The lesion was histologically diagnosed as renal cell carcinoma (clear cell subtype, grade 2) confined by the renal capsule (stage I). No distant metastases were detected. Interferon-alpha was administered every other day as adjuvant chemotherapy. After the patient experienced muscle pain in his thighs and shoulders after exercise on February 11, 1991, the serum creatine phosphokinase (CPK) level progressively increased up to 2,329 U/l. On the basis of the results of various examinations reflecting thyroid gland function, he was diagnosed as having primary hypothyroidism due to Hashimoto's disease. Thyroid function improved after administration of triiodothyronine and thyroxine. Interferon has been reported to influence thyroid function, and, in this case, interferon-alpha therapy may have induced the primary hypothyroidism associated with Hashimoto's disease.


Asunto(s)
Hipotiroidismo/etiología , Interferón-alfa/efectos adversos , Neoplasias Renales/terapia , Quimioterapia Adyuvante , Creatina Quinasa/sangre , Humanos , Hipotiroidismo/diagnóstico , Hipotiroidismo/tratamiento farmacológico , Interferón-alfa/uso terapéutico , Neoplasias Renales/cirugía , Masculino , Persona de Mediana Edad , Nefrectomía , Pruebas de Función de la Tiroides , Hormonas Tiroideas/administración & dosificación , Tiroiditis Autoinmune/complicaciones
9.
Anticancer Drug Des ; 4(2): 137-44, 1989 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-2803462

RESUMEN

The effects of a novel anti-cancer drug, YM 534 on human promyelocytic leukemia line HL-60 cells were investigated. The growth of the cells was completely inhibited with an IC50 of 2.5 X 10(-6) M. The incorporation of 3H-thymidine or 3H-uridine into acid insoluble fraction of the cells was completely inhibited at a 10(-4) M concentration of the drug. However, that of 3H-leucine was suppressed by only 32% at this drug concentration. The single strand scission of DNA of the cells as revealed by alkali sucrose density gradient centrifugation was induced by YM 534 at a 10(-4)M concentration for 60 min. When PM2 DNA in a cell-free system was examined in the presence or absence of reducing agent, no damage to DNA was observed at a 10(-4)M YM 534. The processing of preribosomal to ribosomal RNA of HL-60 cells was retarded at a 10(-5) M level of the drug.


Asunto(s)
Antineoplásicos/uso terapéutico , Imidazoles/uso terapéutico , Leucemia Promielocítica Aguda/tratamiento farmacológico , Antineoplásicos/farmacología , Línea Celular , Daño del ADN , ADN de Neoplasias/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Humanos , Imidazoles/farmacología , Leucemia Promielocítica Aguda/metabolismo , Precursores del ARN/efectos de los fármacos , Precursores del ARN/metabolismo , Procesamiento Postranscripcional del ARN/efectos de los fármacos , ARN Neoplásico/efectos de los fármacos , ARN Neoplásico/metabolismo , ARN Ribosómico/efectos de los fármacos , ARN Ribosómico/metabolismo , Células Tumorales Cultivadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA